FLT3 and acute myeloid leukemia: ITD mutations of the FLT3 gene occur in approximately 21-24% of adult AML patients [14,28] while activating point mutations of the FLT3-TKD, mainly at Asp 835, are found in approximately 5-7% of AML patients [1,45-48].